{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:20:51Z","timestamp":1787656851914,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05079-3","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T06:32:38Z","timestamp":1775370758000},"page":"3557-3566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical assessment of vimentin expression and Ki-67 proliferation index in conventional urothelial carcinoma: a study of 60 Egyptian patients"],"prefix":"10.1007","volume":"58","author":[{"given":"Heba M. K.","family":"Youssef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Hassan","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkarim","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhadi","family":"Samman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Abdelwahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan A.","family":"Baloush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"Noorwali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deema","family":"Abu Al-Teen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Zakaria","family":"El Bostany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Samir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essam","family":"Mandour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Rabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Ehab M.","family":"Shokery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,5]]},"reference":[{"issue":"8","key":"5079_CR1","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney LALM (2020) The global burden of urinary bladder cancer: an update. World J Urol 38(8):1895\u20131904. https:\/\/doi.org\/10.1007\/s00345-019-02984-4","journal-title":"World J Urol"},{"key":"5079_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12939-023-02084-1","volume":"23","author":"AH Mousavian","year":"2024","unstructured":"Mousavian AH, Shafiee G, Sheidaei A et al (2024) The 15-year national trends of urinary cancers incidence among Iranian men and women; 2005\u20132020. Int J Equity Health 23:13. https:\/\/doi.org\/10.1186\/s12939-023-02084-1","journal-title":"Int J Equity Health"},{"issue":"4","key":"5079_CR3","doi-asserted-by":"publisher","first-page":"235237352513953","DOI":"10.1177\/23523735251395361","volume":"11","author":"E Tomiyama","year":"2025","unstructured":"Tomiyama E, Urabe F, Fujita K, Kimura T, Nonomura N, Black PC (2025) Urothelial carcinoma and the potential clinical application of urinary extracellular vesicles: current status and prospects. Bladder Cancer 11(4):23523735251395360. https:\/\/doi.org\/10.1177\/23523735251395361","journal-title":"Bladder Cancer"},{"key":"5079_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s43162-025-00412-1","volume":"37","author":"M El-Kassas","year":"2025","unstructured":"El-Kassas M, Ezzat R, Shousha H et al (2025) Mapping cancer in Egypt: a model to predict future cancer situation using estimates from GLOBOCAN 2020. Egypt J Intern Med 37:31. https:\/\/doi.org\/10.1186\/s43162-025-00412-1","journal-title":"Egypt J Intern Med"},{"issue":"5","key":"5079_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00428-015-1739-2","volume":"466","author":"E Comp\u00e9rat","year":"2015","unstructured":"Comp\u00e9rat E, Larr\u00e9 S, Roupret M et al (2015) Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch 466(5):589\u2013594. https:\/\/doi.org\/10.1007\/s00428-015-1739-2","journal-title":"Virchows Arch"},{"issue":"1","key":"5079_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.21037\/tau.2019.01.09","volume":"8","author":"P Baumeister","year":"2019","unstructured":"Baumeister P, Zamboni S, Mattei A et al (2019) Histological variants in non-muscle invasive bladder cancer. Transl Androl Urol 8(1):34. https:\/\/doi.org\/10.21037\/tau.2019.01.09","journal-title":"Transl Androl Urol"},{"issue":"22","key":"5079_CR7","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3390\/diagnostics14222501","volume":"14","author":"T Cano Barbadilla","year":"2024","unstructured":"Cano Barbadilla T, \u00c1lvarez P\u00e9rez M, Prieto Cuadra JD et al (2024) The role of immunohistochemistry as a surrogate marker in molecular subtyping and classification of bladder cancer. Diagnostics 14(22):2501. https:\/\/doi.org\/10.3390\/diagnostics14222501","journal-title":"Diagnostics"},{"issue":"1","key":"5079_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/ijbs.77181","volume":"19","author":"S Monteiro-Reis","year":"2023","unstructured":"Monteiro-Reis S, Miranda-Gon\u00e7alves V, Guimar\u00e3es-Teixeira C et al (2023) Vimentin epigenetic deregulation in bladder cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition. Int J Biol Sci 19(1):1\u201312. https:\/\/doi.org\/10.7150\/ijbs.77181","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5079_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3329\/jrpmc.v10i1.81515","volume":"10","author":"MZ Islam","year":"2025","unstructured":"Islam MZ, Ahamed S, Rashid MHO, Rahman M, Afroze T (2025) Expression of vimentin, p53, and Ki-67 in urothelial carcinoma of urinary bladder: correlation with histologic grade and muscle invasion. J Rang Med Col 10(1):10\u201315. https:\/\/doi.org\/10.3329\/jrpmc.v10i1.81515","journal-title":"J Rang Med Col"},{"issue":"17","key":"5079_CR10","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.3390\/cancers13174455","volume":"13","author":"MG Davey","year":"2021","unstructured":"Davey MG, Hynes SO, Kerin MJ, Miller N, Lowery AJ (2021) Ki-67 as a prognostic biomarker in invasive breast cancer. Cancers (Basel) 13(17):4455. https:\/\/doi.org\/10.3390\/cancers13174455","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5079_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/clinpract16010009","volume":"16","author":"S Harsanyi","year":"2026","unstructured":"Harsanyi S, Novakova ZV, Ziaran S, Danisovic L, Bevizova K (2026) Comment on Hasan et al. clinico-pathological features and immunohistochemical comparison of p16, p53, and Ki-67 expression in muscle-invasive and non-muscle-invasive conventional urothelial bladder carcinoma. Clin. Pract. 2023, 13, 806\u2013819. Clin Pract 16(1):9. https:\/\/doi.org\/10.3390\/clinpract16010009","journal-title":"Clin Pract"},{"key":"5079_CR12","doi-asserted-by":"publisher","first-page":"109.e21","DOI":"10.1016\/j.urolonc.2021.09.018","volume":"40","author":"CH Yang","year":"2022","unstructured":"Yang CH, Weng WC, Ou YC et al (2022) Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: a retrospective cohort study from bench to bedside. Urol Oncol 40:109.e21-109.e30. https:\/\/doi.org\/10.1016\/j.urolonc.2021.09.018","journal-title":"Urol Oncol"},{"key":"5079_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02475-w","volume":"18","author":"J Lobo","year":"2020","unstructured":"Lobo J, Monteiro-Reis S, Guimar\u00e3es-Teixeira C et al (2020) Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression. J Transl Med 18:303. https:\/\/doi.org\/10.1186\/s12967-020-02475-w","journal-title":"J Transl Med"},{"issue":"6","key":"5079_CR14","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1158\/1078-0432.CCR-06-2330","volume":"13","author":"E Baumgart","year":"2007","unstructured":"Baumgart E, Cohen MS, Silva Neto B et al (2007) Identification and prognostic significance of an epithelial\u2013mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 13(6):1685\u20131694. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2330","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5079_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4103\/0377-4929.107777","volume":"55","author":"P Paliwal","year":"2012","unstructured":"Paliwal P, Arora D, Mishra AK (2012) Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale. Indian J Pathol Microbiol 55(4):443\u2013449","journal-title":"Indian J Pathol Microbiol"},{"key":"5079_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/204759","volume":"2015","author":"AH Rahmani","year":"2015","unstructured":"Rahmani AH, Babiker AY, AlWanian WM et al (2015) Association of cytokeratin and vimentin protein in the genesis of transitional cell carcinoma of urinary bladder patients. Dis Markers 2015:204759. https:\/\/doi.org\/10.1155\/2015\/204759","journal-title":"Dis Markers"},{"issue":"2","key":"5079_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/cpr.12096","volume":"47","author":"X Ding","year":"2014","unstructured":"Ding X, Wang Y, Ma X et al (2014) Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition. Cell Prolif 47(2):146\u2013151. https:\/\/doi.org\/10.1111\/cpr.12096","journal-title":"Cell Prolif"},{"issue":"2","key":"5079_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1590\/S1677-5538.IBJU.2014.02.07","volume":"40","author":"J Zhao","year":"2014","unstructured":"Zhao J, Dong D, Sun L, Zhang G, Sun L (2014) Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer. Int Braz J Urol 40(2):179\u2013189. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2014.02.07","journal-title":"Int Braz J Urol"},{"key":"5079_CR19","doi-asserted-by":"publisher","DOI":"10.12865\/CHSJ.41.03.05","author":"AE Stepan","year":"2015","unstructured":"Stepan AE, Ciuc\u0103 M, Simionescu C, Stepan D, M\u0103rg\u0103ritescul C (2015) Immunoexpression of N-cadherin, Twist and vimentin in bladder urothelial carcinomas. Curr Health Sci J. https:\/\/doi.org\/10.12865\/CHSJ.41.03.05","journal-title":"Curr Health Sci J"},{"key":"5079_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract13040073","author":"A Hasan","year":"2023","unstructured":"Hasan A, Mohammed Y, Basiony M et al (2023) Clinico-pathological study evaluating Ki-67 13% cut-off in Egyptian TURBT cohort. Clin Pract. https:\/\/doi.org\/10.3390\/clinpract13040073","journal-title":"Clin Pract"},{"issue":"4","key":"5079_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1159\/000539417","volume":"68","author":"H Ose","year":"2024","unstructured":"Ose H, Nakamura A, Nukaya T et al (2024) p53 and vimentin double immunostaining to differentiate between high-grade urothelial carcinoma cells and benign atypical cells. Acta Cytol 68(4):359\u2013367. https:\/\/doi.org\/10.1159\/000539417","journal-title":"Acta Cytol"},{"key":"5079_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58586-7","volume":"14","author":"C Zhang","year":"2024","unstructured":"Zhang C, Xu X, Wang T et al (2024) Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1\/Vimentin to detect urothelial carcinoma of the bladder. Sci Rep 14:7941. https:\/\/doi.org\/10.1038\/s41598-024-58586-7","journal-title":"Sci Rep"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05079-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:40:29Z","timestamp":1787654429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05079-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5079"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05079-3","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,5]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Provided from Al-Azhar Assiut faculty of medicine\u00a0IRB.ID: RESEARCH\/AZ.AST\/PAT005\/7\/244\/5\/2025.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA and waived from the ethical committee.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}